Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes : subgroup analysis of the randomized CAROLINA trial

Search this article

Journal

Details 詳細情報について

Report a problem

Back to top